Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
McKesson
Express Scripts
US Army
Harvard Business School

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 6,030,778

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,030,778
Title: Diagnostic assays and kits for body mass disorders associated with a polymorphism in an intron sequence of the SR-BI gene
Abstract:The present invention is based at least in part on the discovery of a polymorphism in the human SR-BI gene which is genetically linked with a high body mass index. Accordingly, the invention provides diagnostic assays and kits for determining whether a subject has or is at risk of developing an abnormal body mass index, such as a high body mass.
Inventor(s): Acton; Susan Laurene (Lexington, MA), Ordovas; Jose M. (Framingham, MA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:08/890,979
Patent Claims:see list of patent claims

Details for Patent 6,030,778

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Millennium Pharmaceuticals, Inc. (Cambridge, MA) 2037-11-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Millennium Pharmaceuticals, Inc. (Cambridge, MA) 2037-11-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Millennium Pharmaceuticals, Inc. (Cambridge, MA) 2037-11-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Chinese Patent Office
McKesson
Argus Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.